Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report

AYGEN B., DEMİR A. M. , GÜMÜŞ M., Karabay O., Kaymakoglu S. , KÖKSAL A. Ş. , ...Daha Fazla

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.29, sa.3, ss.259-269, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 29 Konu: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/tjg.2018.18263
  • Sayfa Sayıları: ss.259-269


This consensus report includes expert opinions and recommendations regarding the screening, and if necessary, the follow-up, prophylaxis, and treatment of hepatitis B before the treatment in patients who will undergo immunosuppressive therapy due to the risk of hepatitis B reactivation emergency. To increase awareness regarding the risk of hepatitis B reactivation in immunosuppressive patients, academicians from several university health research and training centers across Turkey came together and discussed the importance of the subject, current status, and issues in accordance with the current literature data and presented solutions.